Biopharmaceutical News and Research

RSS
Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

New drug shows promise in treating a movement disorder associated with Huntington's disease

New drug shows promise in treating a movement disorder associated with Huntington's disease

New study reveals oral opaganib's potent in vitro activity against Omicron

New study reveals oral opaganib's potent in vitro activity against Omicron

EMA issues qualification opinion for islet autoantibodies as enrichment biomarkers for T1D prevention trials

EMA issues qualification opinion for islet autoantibodies as enrichment biomarkers for T1D prevention trials

ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

The Nucleic Acid Experts – Certified Twice!

The Nucleic Acid Experts – Certified Twice!

Texas A&M team continues research on the potential cure for Menkes disease

Texas A&M team continues research on the potential cure for Menkes disease

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

Single Use Support brings cell & gene therapy expert Katy Spink on board

Single Use Support brings cell & gene therapy expert Katy Spink on board

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Integrity Bio and LakePharma Become Curia

Integrity Bio and LakePharma Become Curia

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

Aceto consolidates acquisition of six manufacturers, strengthening its unique hybrid model that provides major supply chain benefits to customers

Aceto consolidates acquisition of six manufacturers, strengthening its unique hybrid model that provides major supply chain benefits to customers

New production method developed to freeze-dry COVID-19 vaccines

New production method developed to freeze-dry COVID-19 vaccines

Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

Porter Alliance for Innovative Medicines aims to close the gap between scientific research and clinical care

Porter Alliance for Innovative Medicines aims to close the gap between scientific research and clinical care

PhoreMost expands into new facility at Unity Campus, Cambridge, UK

PhoreMost expands into new facility at Unity Campus, Cambridge, UK

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix